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Abstract
Low circulating levels of total 25-hydroxyvitamin D (25(OH)D) have been associated with an increased risk of adverse effects after cardiac surgery. The
metabolites, 25(OH)D2 and 25(OH)D3, provide a good index of vitamin D status. In this study, we examined the association between preoperative plasma
levels of total 25(OH)D, 25(OH)D2 and 25(OH)D3 and the risk of postoperative atrial fibrillation (POAF) following open heart surgery. The levels of
plasma 25(OH)D2 and 25(OH)D3 in 118 patients, who underwent coronary artery bypass grafting and/or valvular surgery, were measured immediately
prior to surgery and on postoperative day 3 by liquid chromatography–tandem mass spectrometry. Patients who developed POAF had higher median
plasma levels of 25(OH)D2 than those who remained in sinus rhythm (SR) (P= 0·003), but no significant difference was noted in levels of 25(OH)D3
or total 25(OH)D between the two groups (P> 0·05). By univariate analysis, patients with total 25(OH)D and 25(OH)D2 levels above the median had
higher frequency of POAF (P< 0·05) and the incidence of POAF increased significantly with each higher quartile of preoperative plasma levels of
25(OH)D2 (P= 0·001), an association that was independent of confounding factors. In both the SR and POAF groups, the median plasma levels of
25(OH)D2, 25(OH)D3 and total 25(OH)D were lower (P< 0·05) on the third postoperative day compared with preoperatively. Our findings demonstrate
that higher plasma levels of 25(OH)D2 are associated with increased risk of POAF, while this is not the case for 25(OH)D3 or total 25(OH)D. The reason
for these discrepant results is not clear but warrants further study.
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Low levels of total 25-hydroxyvitamin D (25(OH)D), the
major circulating form of vitamin D, have been associated
with various adverse outcomes following open heart surgery,
including in-hospital death, myocardial infarction, low cardiac
output states and stroke(1–3).
The most important vitamin D compounds are vitamin D2
(ergocalciferol), found in plants and consumed as a supple-
ment or in fortified foods, and vitamin D3 (cholecalciferol),
which is synthesised in the human epidermis under the influ-
ence of sunlight or consumed in oily fish, fortified foods or as
a supplement. 25-Hydroxyergocalciferol (25(OH)D2) and
25-hydroxycholecalciferol (25(OH)D3), which are generally
considered to reflect an individual’s overall vitamin D status,
are produced by hydroxylation in the liver(4). In the kidney,
part of total 25(OH)D is converted to the active form of vita-
min D, 1,25-dihydroxyvitamin D (1,25(OH)2D), which plays
Abbreviations: 1,25(OH)2D, 1,25-dihydroxyvitamin D; 25(OH)D, 25-hydroxyvitamin D; AF, atrial fibrillation; POAF, postoperative atrial fibrillation; SR, sinus rhythm.
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an important role in the regulation of mineral homeostasis and
has beneficial effects on cardiovascular function and the
immune system(5).
A relationship between vitamin D deficiency and the devel-
opment of atrial fibrillation (AF) has been suggested, although
reported studies have yielded somewhat conflicting results(6–8).
However, no studies exist on the possible role of vitamin D
metabolites in the development of postoperative AF
(POAF), which is surprising in view of the association of vita-
min D deficiency with adverse outcomes after cardiac
surgery(1–3).
Therefore, this study was carried out to investigate whether
higher preoperative plasma levels of 25(OH)D2, 25(OH)D3
and total 25(OH)D are associated with lower incidence of
POAF in patients undergoing open heart surgery.
Materials and methods
Subjects
This study was based on prospectively collected data from a
randomised, double-blind, placebo-controlled clinical trial
designed to examine the effect of n-3 long-chain PUFA on
the occurrence of POAF in patients who underwent coronary
artery bypass grafting and/or valvular repair surgery. The
study was approved by the Bioethics Committee of
Landspitali – The National University Hospital of Iceland
(62/2004). All patients provided written informed consent.
Details of the study design have been published previously(9).
In brief, patients scheduled for elective or semi-urgent open
heart surgery were evaluated for participation. Patients
younger than 40 years of age, those with a history of supraven-
tricular arrhythmia or use of the antiarrhythmic medications
amiodarone and/or sotalol, and patients undergoing emer-
gency surgery were excluded. Prior to surgery, all participants
answered a questionnaire on lifestyle issues, including con-
sumption of fish and cod liver oil, intake of supplemental
n-3 long-chain PUFA capsules, smoking habits, alcohol con-
sumption, height, body weight and medication use. The active
treatment consisted of two Omega-3 Forte capsules twice
daily, providing a total of 1240 mg of EPA ethyl ester and
1000 mg of DHA ethyl ester but no vitamin D (Omega
Forte; Lysi Inc.). The placebo group received 2 g of olive oil
in identical capsules (Lysi Inc.). The treatment was initiated
5–7 d before the scheduled date of surgery and continued
until the day of discharge from the hospital or for a maximum
duration of 2 weeks after the surgery. All patients underwent
continuous electrocardiaographic monitoring while hospita-
lised and the study endpoint, POAF, was defined as an epi-
sode of AF lasting more than 5 min.
Measurement of plasma 25-hydroxyvitamin D2 and D3
Plasma samples obtained both immediately before the surgery
(preoperatively) and on the third postoperative day (postopera-
tively), when the risk for POAF is high, were available for 118
of the 168 original randomised controlled trial participants.
The plasma samples were stored at −76°C until analysis for
25(OH)D2 and 25(OH)D3 using an MS/MS Vitamin D Kit
(Perkin Elmer), and carried out as described previously(10).
Briefly, 30 µl of serum were deproteinised in microtitre plates
using 120 µl acetonitrile containing [2H3]25(OH)D2 and
[2H3]25(OH)D3 as internal standards. The supernatants were
transferred to fresh plates and dried under a gentle flow of
N2. Subsequently, the samples were derivatised using
4-phenyl-1,2,4-triazoline-3,5-dione (PTAD) dissolved in aceto-
nitrile. The derivatisation reaction was quenched in quenching
solution and the samples were subjected to liquid chromatog-
raphy–tandem mass spectrometry (LC-MS/MS) analysis. The
LC-MS/MS system consisted of a CTC PAL Autosampler
(CTC Analytics), a Thermo Surveyor LC pump and a
Thermo TSQ Ultra Triple Quadrupole mass spectrometer
(Thermo Scientific). Separation was achieved using a
Thermo Gold Hypersil C18 column (50 × 2·1 mm, 3 µm).
The analytes were detected as methylamine adducts and
the following transitions were used: 619·3/298·1 and
607·3/298·1 for 25(OH)D2 and 25(OH)D3, respectively,
622·3/301·1 and 610·3/298·1 for 25(OH)D2 and 25(OH)D3
internal standards, respectively, and 625·3/298·1 and
613·3/298·1 for 25(OH)D2 and 25(OH)D3 calibration stan-
dards, respectively. The assay does not differentiate between
epi-25(OH)D3 and 25(OH)D3. Thus the level reported for
25(OH)D3 includes any epi form if present, but the detected
level of 25(OH)D2 is unaffected by the epi form. Total plasma
25(OH)D was calculated as the sum of the plasma levels of
25(OH)D2 and 25(OH)D3. The correctness of the method
was confirmed through participation in the external control
program DEQAS.
Measurement of plasma postoperative C-reactive protein
Routine postoperative care included daily measurements of
C-reactive protein using a sandwich enzyme immunoassay
(Vitros 5.1 FS Chemistry System; Ortho-Clinical Diagnostic).
Statistical analyses
Mann–Whitney or χ2 tests were used to compare the sinus
rhythm (SR) and POAF groups with respect to baseline
characteristics. The Wilcoxon signed-rank test was used to
compare the differences in plasma levels of 25(OH)D2,
25(OH)D3 and total 25(OH)D between time points in the
two study groups. To examine the association between
POAF and the preoperative plasma levels of 25(OH)D2,
25(OH)D3 and total 25(OH)D, we compared the rate of
POAF between dichotomised levels and quartiles of plasma
25(OH)D2, 25(OH)D3 and total 25(OH)D using the χ
2 test
and Somers’ d test for ordinal variables. A stepwise multivariable
logistic regression was used to examine factors associated with
POAF. In the original investigation, there was no difference in
POAF incidence between the active treatment and placebo
groups, and no association between treatment and outcome.
Hence, we have ignored treatment allocation in our analyses.
Multivariable linear regression analysis was used to assess pre-
dictors of the preoperative plasma levels of 25(OH)D2 and
25(OH)D3 in the whole study group. Data are presented as
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medians and ranges, percentages or means with their standard
errors. A two-sided P value <0·05 was considered statistically
significant. All statistical analyses were carried out using SPSS
(version 21.0; IBM Corporation).
Results
Baseline characteristics
The baseline characteristics of the patients in the SR (n 52) and
POAF (n 66) groups are shown in Table 1. The patients with
POAF were older (P = 0·001), they comprised fewer smokers
(P= 0·041), and they consumed fish more frequently (P =
0·034) than the SR group. Immediately before the surgery
and on the third postoperative day, the median plasma level
of 25(OH)D2 was higher in the POAF group than in the SR
group (P = 0·003 and P = 0·040, respectively) (Table 2).
However, the differences in levels of 25(OH)D3 or total
25(OH)D between the two groups were not significant. In
both the SR and POAF groups, the median plasma levels of
25(OH)D2, 25(OH)D3 and total 25(OH)D were lower (P <
0·05) on the third postoperative day compared with the pre-
operative values (Table 2).
Association of plasma 25-hydroxyvitamin D2 and D3 levels
with postoperative atrial fibrillation
The incidence of POAF was higher (P < 0·05) in those with
preoperative plasma levels above the median for 25(OH)D2
(≥1·1 nmol/l) and total 25(OH)D (≥47·1 nmol/l) compared
with those below the median, whereas the difference was
of borderline significance (P = 0·06) for 25(OH)D3 (≥45·9
nmol/l) (Fig. 1). When the patients were divided into quartiles
based on preoperative plasma levels of 25(OH)D2 and
25(OH)D3, the POAF incidence differed for the 25(OH)D2
levels (P = 0·020), with a significant linear trend for an increas-
ing incidence of POAF observed with the higher quartiles
(P= 0·001) (Fig. 2). The difference in POAF incidence observed
between the quartiles of 25(OH)D3 and total 25(OH)D
levels demonstrated a non-significant J-shaped curve (P> 0·05).
Multivariable logistic regression analysis, adjusting for fac-
tors known or presumed to affect POAF, showed that higher
preoperative plasma levels of 25(OH)D2 were associated with
higher risk of developing POAF with OR of 2·747 (95 %
CI 1·121, 6·734; P = 0·027), while no significant association
between POAF and plasma levels of 25(OH)D3 or total
25(OH)D was observed (Table 3).
Factors predicting the plasma levels of 25-hydroxyvitamin D2
and D3
In the multivariable linear regression model, the preoperative
plasma level of 25(OH)D2 was negatively associated with alco-
hol consumption (β =−0·210; P = 0·024), but no association
with the n-3 long-chain PUFA treatment and other factors was
detected. To the contrary, 25(OH)D3 was positively associated
Table 2. Plasma vitamin D levels of patients in the sinus rhythm (SR) and
postoperative atrial fibrillation (POAF) groups, immediately before cardiac
surgery (preoperative) and on the third postoperative day (postoperative)
(Medians and ranges)
Preoperative Postoperative
Median Range Median Range P*
SR group (n 52)
25(OH)D2 (nmol/l) 0·8 0·0–4·4 0·75 0·0–3·2 0·003
25(OH)D3 (nmol/l) 37·8 7·4–89·1 29·4 7·6–71·3 <0·001
Total 25(OH)D
(nmol/l)
39·3 8·1–90·5 30·5 8·6–72·2 <0·001
POAF group (n 66)
25(OH)D2 (nmol/l) 1·3† 0·0–20·8 1·0† 0·0–13·2 <0·001
25(OH)D3 (nmol/l) 51·6 8·6–83·5 37·7 7·3–76·0 <0·001
Total 25(OH)D
(nmol/l)
52·4 8·6–84·9 38·3 7·3–77·3 <0·001
25(OH)D, 25-hydroxyvitamin D.
* Compared with preoperative 25(OH)D2, 25(OH)D3 or total 25(OH)D levels
(Wilcoxon signed-rank test).
†Median value was significantly different from that of the SR group (P < 0·05; Mann–
Whitney test).
Table 1. Characteristics of the study subjects
(Medians and ranges, or percentages)
SR group (n 52) POAF group (n 66)
Median Range Median Range P*
Age (years) 64·0 43–79 70·5 45–82 0·001
BMI (kg/m2) 28·0 20·9–41·3 27·1 21·0–38·1 0·86
Sex (% men) 78·8 81·8 0·69
Smokers (%) 26·9 12·1 0·04
Alcohol consumption ≥once per week (%) 67·3 74·2 0·42
Fish intake ≥once a week (%) 59·6 78·8 0·03
Use of liquid cod liver oil (%)† 50·0 54·5 0·70
Use of n-3 long-chain PUFA capsules (%)† 19·2 31·8 0·14
n-3 Long-chain PUFA treatment (%) 50·0 53·0 0·74
Diabetes (%) 17·3 12·1 0·43
Treatment with statins (%) 84·6 72·7 0·12
CABG only (%) 78·8 66·7 0·15
Total blood volume in drains (ml) 710 175–3070 800 96–4980 0·58
SR, sinus rhythm; POAF, postoperative atrial fibrillation; CABG, coronary artery bypass grafting.
* Compared with the SR group (Mann–Whitney test or χ2 test).
†Prior to study treatment.
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with cod liver oil supplementation (β = 0·406; P < 0·001) and
alcohol consumption (β = 0·193; P= 0·022), but negatively
associated with diabetes (β =−0·217; P = 0·012) and smoking
(β =−0·206; P = 0·014).
Discussion
In this study, we found higher preoperative plasma 25(OH)D2
levels to be associated with an increased risk of POAF.
In contrast, we did not observe an association between plasma
levels of 25(OH)D3 or total 25(OH)D and the incidence of
POAF. The plasma levels of both 25(OH)D2 and 25(OH)D3
decreased in the early postoperative period.
Previous studies suggest that deficiency of total 25(OH)D is
associated with increased prevalence of electrocardiographic
abnormalities(11). In a recent prospective cohort study of
patients undergoing cardiac surgery, low total 25(OH)D levels
were independently associated with the risk of major cardiac
and cerebrovascular events (MACCE)(1), although the investi-
gators did not report whether a relationship existed between
25(OH)D and the development of POAF. However, previous
work has elucidated a potential role of total 25(OH)D in the
development of non-valvular AF(6,7). The results of the pre-
sent study, following adjustment for age, BMI, smoking,
peak postoperative C-reactive protein, preoperative plasma
DHA level and valvular surgery or complex surgical proced-
ure(12), showed that higher preoperative plasma levels of
25(OH)D2 were related to the development of POAF. To
the contrary, neither 25(OH)D3 nor total 25(OH)D levels
were associated with POAF. This finding was somewhat sur-
prising, since median plasma 25(OH)D2 levels in humans are
generally low, as exemplified by the patients in the present
study. In the POAF group, the highest plasma 25(OH)D2
level was 20·8 nmol/l compared with 4·4 nmol/l in the SR
group. A recent study demonstrated the distribution of
serum 25(OH)D2 concentrations in samples of Irish adults
(n 884), of whom 78·8 % had concentrations above the limit
of quantification (1·43 nmol/l), the median concentration
being 2·96 nmol/l, and the maximum concentration 27·64
nmol/l(13). According to the authors, the distribution of the
serum 25(OH)D2 data suggests that vitamin D2 is ubiquitous
in the diet, regardless of food sources. It is therefore likely
that dietary differences between study populations explain
the observed difference in the levels of 25(OH)D2. While a
causal link for the observed association might be sought in
the effects of 25(OH)D2 on cardiac function or rhythm, oxi-
dative stress or inflammatory pathways, this remains specula-
tive and it is important that our findings be confirmed in
larger studies.
Fig. 1. Incidence of postoperative atrial fibrillation (POAF) according to dichot-
omised preoperative plasma levels of 25-hydroxyvitamin D2 (25(OH)D2),
25(OH)D3, and total 25(OH)D in patients undergoing open heart surgery.
Median levels ≥1·1 nmol/l for 25(OH)D2; ≥45·9 nmol/l for 25(OH)D3; ≥47·1
nmol/l for total 25(OH)D. Data were analysed by Pearson’s χ2. , Below
median; ■, above median.
Fig. 2. Incidence of postoperative atrial fibrillation (POAF) according to quar-
tiles of the preoperative plasma levels (nmol/l) of 25-hydroxyvitamin D2
(25(OH)D2; --Δ--), 25(OH)D3 (–■–) and total 25(OH)D (--○--) in patients under-
going open heart surgery. Data were analysed by Pearson’s χ2 and Somers’ d
statistics for trend in association between ordinal variables.
Table 3. Multivariable logistic regression analysis of factors associated
with postoperative atrial fibrillation*
R2 OR 95 % CI P
Age (years) 0·127 1·07 1·03, 1·12 0·001
Peak postoperative CRP (mg/l) 0·195 1·01 1·00, 1·01 0·02
Plasma preoperative DHA (%) 0·241 2·63 1·10, 6·28 0·03
Smoking (reference, non-smoker) 0·275 0·37 0·13, 1·05 0·06
Type of surgery (reference, valvular
or complex procedure)
0·304 0·42 0·16, 1·12 0·08
BMI (kg/m2) 0·308 0·96 0·85, 1·08 0·47
25(OH)D2 (reference, lower half)† 0·352 2·75 1·12, 6·73 0·03
25(OH)D3 (reference, lower half)† 0·309 1·10 0·45, 2·66 0·83
Total 25(OH)D (reference, lower
half)†
0·311 1·31 0·54, 3·16 0·55
R2, Nagelkerke’s R2; CRP, C-reactive protein; 25(OH)D, 25-hydroxyvitamin D.
* Stepwise forward selection of variables, 25(OH)D2, 25(OH)D3 and total 25(OH)D
added in the final step in three different models. Cumulative R2 for each step of
the regression analysis.




Our study did not have enough power to examine MACCE
in relation to vitamin D levels. Prior studies evaluating this
association have not examined 25(OH)D2 and 25(OH)D3 sep-
arately, only total 25(OH)D(6,7). Hence, it remains unclear
whether the effect of the two forms of vitamin D might
also be different with respect to MACCE. Nevertheless, it is
possible that failure to account for a differential effect of
25(OH)D2 and 25(OH)D3 may explain inconsistency in the
results of studies examining the association between vitamin
D and AF, an important issue that needs to be addressed in
future studies.
Among the conditions that have been linked to deficiency of
circulating total 25(OH)D are type 2 diabetes and hyperten-
sion, although randomised clinical trials and meta-analyses
have yielded inconclusive results(14,15). Recent studies have
also shown that exposure to cigarette smoke is associated with
lower circulating levels of total 25(OH)D and 25(OH)D3
(16,17).
Our findings are consistent with data suggesting that low
25(OH)D3 levels are associated with diabetes and cigarette
smoking(14,17). It has long been known that excessive alcohol
consumption results in perturbations in vitamin D metabolism
and that individuals suffering from chronic alcoholism usually
have lower levels of circulating total 25(OH)D than non-
drinkers(18). However, the results of our study suggest that
moderate alcohol consumption may result in lower levels of
25(OH)D2 and higher 25(OH)D3 levels, the latter of which
is in line with previous reports(19,20). Thus, our findings indi-
cate that both lifestyle and disease states are related to circulat-
ing levels of vitamin D metabolites. Decrease in the plasma
25(OH)D3 level following cardiac surgery may reflect
increased conversion into the active form, 1,25(OH)2D
(1,20).
The effects of anaesthesia and other factors associated with
open heart surgery, such as fluid administration, blood loss,
fluid shifts and leak of vitamin D-binding proteins into the
interstitial space, may also have contributed to the decrease
in circulating 25(OH)D levels in the early postoperative per-
iod(2,21). Additional supplementation of vitamin D3 in these
patients may be required.
While the results of the current study are intriguing, the
study is limited by its relatively small sample size, precluding
the analysis of more definitive endpoints such as mortality
or major complications of the surgical procedure. The sample
size is also too limited to reliably examine non-linear relation-
ships between the plasma levels of total 25(OH)D, 25(OH)D2
and 25(OH)D3, and the outcome of interest. However, all
patients had plasma levels of total 25(OH)D below 100
nmol/l which is believed to reflect scarcity of 1,25(OH)2D,
leading to deficient rather than excessive vitamin D effects(1).
Furthermore, the association between PAOF and total
25(OH)D and 25(OH)D3 observed in the univariate analysis
may have been rendered insignificant in the multivariate
model due to lack of power. Thus, it is important to examine
this association in a larger study. The blood samples from the
patients were collected throughout the year and circulating
total 25(OH)D levels were found to be independent of season
(data not shown). This is in accordance with work demonstrat-
ing that there is no seasonal variation in circulating total
25(OH)D levels in elderly Icelandic patients, who are living
in a country which is geographically located at 64°N and
where the use of cod liver oil supplementation is common(22).
The plasma 25(OH)D2 levels were lower in our patients
than has been reported previously. This finding is hard to
explain by analytical measurement uncertainty, the only plaus-
ible exception being batch-to-batch variation. However, the
samples were run with matched cases and controls placed
adjacent to each other in order to avoid this phenomenon.
Therefore, batch-to-batch variation is an unlikely explanation
for our findings which can most probably be explained by diet-
ary differences. Finally, this association study cannot establish
a cause-and-effect relationship as unknown confounding fac-
tors may have influenced the results.
In conclusion, higher plasma levels of 25(OH)D2 were asso-
ciated with higher incidence of POAF, whereas no association
was found for plasma levels of total 25(OH)D and 25(OH)D3.
This association of 25(OH)D2 with the risk of POAF needs to
be addressed in future studies.
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